170 related articles for article (PubMed ID: 3764307)
1. Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.
Hawkins SJ; Black CM; Hall ND; McGregor A; Ring EF; Maddison PJ
Rheumatol Int; 1986; 6(2):85-8. PubMed ID: 3764307
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers for primary Raynaud's phenomenon.
Ennis H; Hughes M; Anderson ME; Wilkinson J; Herrick AL
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD002069. PubMed ID: 26914257
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers for primary Raynaud's phenomenon.
Ennis H; Anderson ME; Wilkinson J; Herrick AL
Cochrane Database Syst Rev; 2014 Jan; (1):CD002069. PubMed ID: 24482037
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Malamet R; Wise RA; Ettinger WH; Wigley FM
Am J Med; 1985 Apr; 78(4):602-8. PubMed ID: 3157318
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
6. Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon).
Kahan A; Weber S; Amor B; Menkes CJ; Saporta L; Hodara M; Guerin F; Degeorges M
Eur Heart J; 1983 May; 4 Suppl C():123-9. PubMed ID: 6352267
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
Smith CD; McKendry RJ
Lancet; 1982 Dec; 2(8311):1299-301. PubMed ID: 6128596
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
[TBL] [Abstract][Full Text] [Related]
10. [Calcium antagonists for the treatment of Raynaud's phenomenon].
Müller-Bühl U; Diehm C; Scheuermann W; Mörl H
Dtsch Med Wochenschr; 1983 Nov; 108(47):1795-7. PubMed ID: 6357692
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine in the treatment of idiopathic Raynaud's syndrome.
Sarkozi J; Bookman AA; Mahon W; Ramsay C; Detsky AS; Keystone EC
J Rheumatol; 1986 Apr; 13(2):331-6. PubMed ID: 3723496
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Raynaud's syndrome with calcium entry blockers].
Shcherbakov AB; Guseva NG; Mach ES
Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
14. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T; Hartling OJ; Kelbaek H; Nielsen SL
Eur J Clin Pharmacol; 1986; 31(4):387-9. PubMed ID: 3816916
[TBL] [Abstract][Full Text] [Related]
15. Nisoldipine in primary Raynaud's phenomenon.
Challenor VF; Waller DG; Francis DA; Francis JL; Mani R; Roath S
Eur J Clin Pharmacol; 1987; 33(1):27-30. PubMed ID: 3691593
[TBL] [Abstract][Full Text] [Related]
16. [The therapy of Raynaud's phenomenon].
Di Giacinto G
Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
[TBL] [Abstract][Full Text] [Related]
17. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
[TBL] [Abstract][Full Text] [Related]
18. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
[TBL] [Abstract][Full Text] [Related]
19. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
[TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Smith CR; Rodeheffer RJ
Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
